Functional innervation of the myometrium of Myotis lucifugus, the little brown bat.
Myometria of pregnant and nonpregnant Myotis lucifugus were studied in vitro by using electrical field stimulation as well as autonomic agonists and antagonists to determine whether functional responses corresponded with structural evidence showing abundant adrenergic and sparse cholinergic innervation, which uniquely does not disappear during pregnancy. Field stimulation (70 V, 0.6 ms, 5.0-s pulse train, 2.5 - 60 Hz) of myometria from nonpregnant (hibernating) bats produced graded responses consisting of an initial alpha-adrenergic contraction and a subsequent beta-adrenergic relaxation phase. Responses were sensitive to both the nerve poison tetrodotoxin and the adrenergic antagonist guanethidine, demonstrating that they resulted from stimulation of intrinsic adrenergic nerves. Field stimulation responses were unaffected by atropine indicating that there was no functional cholinergic innervation, even though carbachol-induced contraction showed that muscarinic receptors were present. In contrast, functional innervation of cervical tissue was cholinergic and nonadrenergic-non-cholinergic, but not adrenergic. At the beginning of active gestation, some myometrial preparations exhibited little of no response to field stimulation. However, as uterine size increased, the biphasic response to field stimulation was enhanced, particularly the inhibitory (beta-adrenergic) phase. Moreover, the contractile phases, though reduced, was not abolished by alpha-adrenergic antagonists. The residual contractile response was also tetrodotoxin-resistant, suggesting that the myometrium was sensitive to direct electrical stimulation. Near the end of pregnancy, myometrial tissue became nonresponsive to both field stimulation and autonomic agonists, suggesting an absence of available receptor sites on muscle cells.
Buchanan
G D
GD
Department of Biomedical Sciences McMaster University, Hamilton, Ontario, Canada.
Garfield
R E
RE
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001337:Autonomic Agents / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002584:Cervix Uteri / Q000294:innervation / Q000502:physiology / Q000648:ultrastructure; D002685:Chiroptera / Q000502:physiology*; D004558:Electric Stimulation; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D009132:Muscles / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D009215:Myometrium / Q000294:innervation* / Q000502:physiology / Q000648:ultrastructure; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011247:Pregnancy; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects / Q000502:physiology; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000502:physiology; D014590:Uterine Contraction; D014599:Uterus / Q000294:innervation / Q000502:physiology / Q000648:ultrastructure
D001337:Autonomic Agents; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D010656:Phenylephrine; D001285:Atropine; D002217:Carbachol; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D010646:Phentolamine; D006145:Guanethidine